Clotrimazole-Betamethasone Dipropionate Prescribing for Nonfungal Skin Conditions-Reference-Cited by-同舟云学术

Clotrimazole-Betamethasone Dipropionate Prescribing for Nonfungal Skin Conditions

Published:2024-05-16 Issue:5 Volume:7 Page:e2411721
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Gold Jeremy A. W.¹,Caplan Avrom S.²,Benedict Kaitlin¹,Lipner Shari R.³,Smith Dallas J.¹

Affiliation:

1. Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia

2. Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York

3. Department of Dermatology, Weill Cornell Medicine, New York, New York

Abstract

This cross-sectional study identifies the common diagnoses and physician encounter types associated with clotrimazole-betamethasone dipropionate prescriptions among Medicare enrollees in 2021.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2818756/gold_2024_ld_240059_1715185314.61231.pdf

Reference6 articles.

1. Primary care physicians’ errors in handling cutaneous disorders. A prospective survey.;Pariser;J Am Acad Dermatol,1987

2. Trichophyton indotineae-An emerging pathogen causing recalcitrant dermatophytoses in India and worldwide-a multidimensional perspective.;Uhrlaß;J Fungi (Basel),2022

3. The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone.;Flint;Dermatol Online J,2021

4. Current trends in the use of two combination antifungal/corticosteroid creams.;Wheat;J Pediatr,2017

5. Healthcare provider testing practices for tinea and familiarity with antifungal-drug-resistant tinea-United States, 2022.;Benedict;J Fungi (Basel),2022